Medicus Pharma Ltd.

MDCX Nasdaq SEC CIK 1997296
Follow Medicus Pharma Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$15.2M +27.5% vs same quarter last year
EPS, diluted −$11.64
Operating cash flow −$15.9M −135.9% vs same quarter last year
Operating income −$14.5M +6.3% vs same quarter last year
Net income by quarter
−$3.5M
−$5.1M
−$6.2M
−$20.9M
−$15.1M
−$9M
−$11.6M
−$15.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income4 fiscal years
−$60M−$40M−$20M$0FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$47.3M
FY24−$11.2M
FY23−$5.3M
FY22-